SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.
|
EQS-News: SHOP APOTHEKE EUROPE N.V.
/ Key word(s): Personnel
SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO. Sevenum, the Netherlands, 15 March 2023. The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM. In this position, he will succeed Stefan Feltens, who will retire after the expiration of his current 4-year term on 26 April 2023. Björn Söder, chairman of the SHOP APOTHEKE EUROPE’s Supervisory Board: "On behalf of the entire Supervisory Board, I am delighted to welcome Olaf Heinrich to SHOP APOTHEKE EUROPE. With his extensive experience in the European online pharmacy industry and his broad network nationally and internationally, we are convinced that he is the right person to lead SHOP APOTHEKE EUROPE into its next phase of growth and to further strengthen its position as the leading e-pharmacy in Europe." Born in Hamburg, Olaf worked for the online pharmacy DocMorris from 2008 until 2020, initially as a member of the Management Board. Just under a year later, he became CEO. As a team player with years of experience working at board level in a listed company, he has a deep understanding of the digitalisation of the healthcare systems. As member of the European Association of E-Pharmacies (EAEP) he is known to SHOP APOTHEKE EUROPE’s management for the last 15 years. "I am very excited to join SHOP APOTHEKE EUROPE, an industry leader in the online pharmacy market," says Olaf Heinrich. "I am impressed by the growth and value SHOP APOTHEKE EUROPE has created for its customers and its shareholders over the past years. It is a pleasure for me to lead such a strong company and, together with the team, to generate additional value and to further grow SHOP APOTHEKE EUROPE’S online business." In accordance with Dutch law, Olaf Heinrich will be proposed to be appointed as a member of the managing board by the next general shareholders' meeting of SHOP APOTHEKE EUROPE N.V. which will be held on 26 April 2023. Olaf Heinrich will support SHOP APOTHEKE EUROPE as an advisor even before his official start on 1 August 2023 to get familiarised with his future tasks.
15.03.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | Investor.Relations@shop-apotheke.com |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1583659 |
| End of News | EQS News Service |
|
|
1583659 15.03.2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.